amoxicillin 600 MG / clavulanic acid 42.9 MG per 5 ML Oral Suspension
- RxCUI
- 617993
- RxNorm name
- amoxicillin 600 MG / clavulanic acid 42.9 MG per 5 ML Oral Suspension
- Display name
- amoxicillin 600 MG / clavulanic acid 42.9 MG per 5 ML Oral Suspension
- Full name
- amoxicillin 600 MG / clavulanic acid 42.9 MG per 5 ML Oral Suspension
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:26
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| amoxicillin and clavulanate potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Chartwell RX, LLC | 00b86913-50c8-443f-8467-f4f499d358af | 2026-07-23 | Warnings, Adverse reactions | 617993 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | USAntibiotics, LLC | 7d4dfd6f-bd1a-4acc-8506-07fca08f8a38 | 2026-07-07 | Warnings, Adverse reactions | 617993 |
| AUGMENTIN ES-600 | AMOXICILLIN AND CLAVULANATE POTASSIUM | USAntibiotics, LLC | 59979859-8c9b-4173-a5e3-2e6312fd9d79 | 2026-07-07 | Warnings, Adverse reactions | 617993 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Redpharm Drug | 5250085e-5509-c577-e063-6294a90a9b87 | 2026-05-21 | Warnings, Adverse reactions | 617993 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | fc31a5df-aa1c-4b0f-8c64-a14236df4a02 | 2026-03-05 | Warnings, Adverse reactions | 617993 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 720ee5cf-1962-423b-ac81-6dd4f02b9206 | 2026-03-04 | Warnings, Adverse reactions | 617993 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals, Inc. | 22a387bd-92ce-4ebc-b475-20d7750a2507 | 2026-03-04 | Warnings, Adverse reactions | 617993 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | bcd19a89-e9dc-b85f-e053-2a95a90a6f3e | 2026-02-19 | Warnings, Adverse reactions | 617993 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | 2a376d67-0bf2-43a1-8ca3-73f90689c339 | 2026-02-06 | Warnings, Adverse reactions | 617993 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 16915fe9-1ac9-4ebb-afc8-eeb89144f30c | 2026-01-20 | Warnings, Adverse reactions | 617993 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | Redpharm Drug | 2fbb57ba-08d8-0224-e063-6294a90ab683 | 2025-12-30 | Warnings, Adverse reactions | 617993 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | ebf49514-0bce-ac56-e053-2a95a90ae540 | 2025-12-22 | Warnings, Adverse reactions | 617993 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | ccb8bfb1-1303-4c2d-9106-78684e6b859f | 2025-12-19 | Warnings, Adverse reactions | 617993 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NorthStar Rx LLC | df4136c0-9efd-42c3-a487-e728e8b91275 | 2025-04-03 | Warnings, Adverse reactions | 617993 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Devatis Inc. | a884cff6-bffd-41fd-904c-c694c995f338 | 2025-03-11 | Warnings, Adverse reactions | 617993 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Hikma Pharmaceuticals USA Inc. | 6339bcdb-060f-4558-9f42-6bf7f935e138 | 2025-02-28 | Warnings, Adverse reactions | 617993 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals, Inc. | 2bb03d3b-5d44-bc4a-e063-6394a90a656a | 2025-01-14 | Warnings, Adverse reactions | 617993 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Sandoz Inc | 99b7f40a-06f9-4b97-8eee-8e61e5106aad | 2025-01-08 | Warnings, Adverse reactions | 617993 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | 9ba5b2b2-3c27-a2a8-e053-2a95a90a97cd | 2025-01-02 | Warnings, Adverse reactions | 617993 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Teva Pharmaceuticals USA, Inc. | e83f43dd-f79e-4166-9bee-9427e235c876 | 2024-12-01 | Warnings, Adverse reactions | 617993 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e05caabb-b95c-4e54-890e-bbc371a20fc3 | amoxicillin 600 MG / clavulanic acid 42.9 MG in 5 mL Oral Suspension [PSN] · amoxicillin 120 MG/ML / clavulanate 8.58 MG/ML Oral Suspension [SCD] · amoxicillin (as amoxicillin trihydrate) 600 MG / clavulanic acid (as clavulanate potassium) 42.9 MG per 5 ML Oral Suspension [SY] · amoxicillin 600 MG / clavulanic acid 42.9 MG per 5 ML Oral Suspension [SY] | 4 | 1 | These highlights do not include all the information needed to use AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION safely and effectively. See full prescribing information for AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION. AMOXICILLIN and CLAVULANATE potassium for oral suspension, for oral use Initial U.S. Approval: 2001 | 20231001 |